These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19291539)

  • 21. Use of serum cystatin C to detect early decline of glomerular filtration rate in type 2 diabetes.
    Yang YS; Peng CH; Lin CK; Wang CP; Huang CN
    Intern Med; 2007; 46(12):801-6. PubMed ID: 17575370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of different biomarkers of renal function with D-dimer levels in patients with type 1 diabetes mellitus (renal biomarkers and D-dimer in diabetes).
    Domingueti CP; Fóscolo RB; Dusse LMS; Reis JS; Carvalho MDG; Gomes KB; Fernandes AP
    Arch Endocrinol Metab; 2018 Feb; 62(1):27-33. PubMed ID: 29694626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of serum cystatin C in early evaluation of renal insufficiency in patients undergoing chemotherapy: a systematic review and meta-analysis.
    He L; Li J; Zhan J; Yi F; Fan X; Wei Y; Zhang W
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):561-571. PubMed ID: 30610366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum cystatin C is a potential endogenous marker for the estimation of renal function in male gout patients with renal impairment.
    Choe JY; Park SH; Kim SK
    J Korean Med Sci; 2010 Jan; 25(1):42-8. PubMed ID: 20052346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystatin C as a marker for detection of early renal failure in diabetes type 2 patients.
    Ascić-Buturović B; Cavaljuga S
    Bosn J Basic Med Sci; 2005 Nov; 5(4):68-71. PubMed ID: 16351602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystatin C in acute heart failure without advanced renal impairment.
    Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
    Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.
    Peralta CA; Shlipak MG; Judd S; Cushman M; McClellan W; Zakai NA; Safford MM; Zhang X; Muntner P; Warnock D
    JAMA; 2011 Apr; 305(15):1545-52. PubMed ID: 21482744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Myocardial dysfunction, neuropathy and nephropathy in long standing type 1 diabetic patients].
    Galicka-Latała D; Konduracka E; Kuźniewski M; Fedak D; Sieradzki J
    Przegl Lek; 2005; 62(12):1451-4. PubMed ID: 16786771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults.
    Tsaryk I; Pashkovska N
    J Med Life; 2022 Jun; 15(6):792-796. PubMed ID: 35928354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystatin C and blood pressure: results of 24 h ambulatory blood pressure monitoring.
    Mena C; Robles NR; de Prado JM; Gallego FG; Cidoncha A
    Eur J Intern Med; 2010 Jun; 21(3):185-90. PubMed ID: 20493420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old.
    Van Den Noortgate NJ; Janssens WH; Delanghe JR; Afschrift MB; Lameire NH
    J Am Geriatr Soc; 2002 Jul; 50(7):1278-82. PubMed ID: 12133025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment.
    Coll E; Botey A; Alvarez L; Poch E; Quintó L; Saurina A; Vera M; Piera C; Darnell A
    Am J Kidney Dis; 2000 Jul; 36(1):29-34. PubMed ID: 10873868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spot urine albumin to creatinine ratio and serum cystatin C are effective for detection of diabetic nephropathy in childhood diabetic patients.
    Chae HW; Shin JI; Kwon AR; Kim HS; Kim DH
    J Korean Med Sci; 2012 Jul; 27(7):784-7. PubMed ID: 22787375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Renal Insufficiency in a Cohort of Patients With Beta-thalassemia Major Using Cystatin-C.
    Hamdy M; Shaheen I; El-Gammal ZM; Ramadan YM
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1082-e1087. PubMed ID: 33843816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interest of cystatin C in screening diabetic patients for early impairment of renal function.
    Perlemoine C; Beauvieux MC; Rigalleau V; Baillet L; Barthes N; Derache P; Gin H
    Metabolism; 2003 Oct; 52(10):1258-64. PubMed ID: 14564676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of creatinine and cystatin C for estimation of glomerular filtration rate in pediatric patients after Fontan operation.
    Kirelik D; Fisher M; DiMaria M; Soranno DE; Gist KM
    Congenit Heart Dis; 2019 Sep; 14(5):760-764. PubMed ID: 30993817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the clinical application of cystatin C, a new marker of the glomerular filtration rate, for the initial dose-setting of arbekacin.
    Otsuka T; Tanaka A; Suemaru K; Inoue T; Nishimiya T; Murase M; Araki H
    J Clin Pharm Ther; 2008 Jun; 33(3):227-35. PubMed ID: 18452409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystatin C-based formula is superior to MDRD, Cockcroft-Gault and Nankivell formulae in estimating the glomerular filtration rate in renal allografts.
    Qutb A; Syed G; Tamim HM; Al Jondeby M; Jaradat M; Tamimi W; Al Ghamdi G; Al Qurashi S; Flaiw A; Hejaili F; Al Sayyari AA
    Exp Clin Transplant; 2009 Dec; 7(4):197-202. PubMed ID: 20353367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum cystatin C in pregnant women: reference values, reliable and superior diagnostic accuracy.
    Babay Z; Al-Wakeel J; Addar M; Mittwalli A; Tarif N; Hammad D; Ali N; Al-Askar A; Choudhary AR
    Clin Exp Obstet Gynecol; 2005; 32(3):175-9. PubMed ID: 16433158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum cystatin C and microalbuminuria in the detection of vascular and renal damage in early stages.
    López Gómez JM; Sacristán Enciso B; Micó M; Arias Meneses F; de Sande Medel F; Alejo S
    Nefrologia; 2011; 31(5):560-6. PubMed ID: 21959722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.